loading

Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
7.29%
42.61
45.96 40.43 38.11 34.75
Operating Income/Loss
7.29%
-42.61
-45.96 -40.43 -38.11 -34.75
Income/Loss From Continuing Operations Before Tax
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Income/Loss From Continuing Operations After Tax
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Net Income/Loss
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.31%
104.94
95.13 93.81 93.52 87.57
Diluted Average Shares
10.31%
104.94
95.13 93.81 93.52 87.57
Basic Earnings Per Share
20.93%
-0.34
-0.43 -0.36 -0.34 -0.33
Diluted Earnings Per Share
20.93%
-0.34
-0.43 -0.36 -0.34 -0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.73
price up icon 0.23%
$27.49
price up icon 0.42%
$25.96
price up icon 8.69%
$110.50
price up icon 7.16%
$143.11
price up icon 0.30%
biotechnology ONC
$337.32
price up icon 5.88%
Capitalizzazione:     |  Volume (24 ore):